Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Covington
Julphar
Dow
Moodys
Citi
Merck
Chinese Patent Office

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017565

« Back to Dashboard

NDA 017565 describes NORINYL 1+35 28-DAY, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. Additional details are available on the NORINYL 1+35 28-DAY profile page.

The generic ingredient in NORINYL 1+35 28-DAY is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 017565
Tradename:NORINYL 1+35 28-DAY
Applicant:Allergan Sales Llc
Ingredient:ethinyl estradiol; norethindrone
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 017565
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORINYL 1+35 21-DAY ethinyl estradiol; norethindrone TABLET;ORAL-21 017565 NDA Actavis Pharma, Inc. 52544-259 N 52544-259-28
NORINYL 1+35 28-DAY ethinyl estradiol; norethindrone TABLET;ORAL-28 017565 NDA Actavis Pharma, Inc. 52544-259 N 52544-259-28

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-21Strength0.035MG;1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
UBS
Healthtrust
Moodys
Medtronic
Boehringer Ingelheim
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.